Sarcoma Coding Inaccurate in Most Cases – CTOS Annual Meeting

by | Posted: Nov 22, 2017 | Medical Coding

Share this post:

A diverse family of rare cancers, sarcomas can develop in connective tissues and affect virtually any part of the body. Sarcomas grow in connective tissue – cells that connect or support other kinds of tissue in your body. As different types of sarcomas exist, the diagnosis, treatment, research and policy-making surrounding them is challenging. Medical coding service for this particular condition requires better understanding of the existing codes and documentation/reimbursement guidelines. The study results presented at the 22nd Connective Tissue Oncology Society (CTOS) 2017 Annual Meeting found that ICD-9/ICD-10 coding is inaccurate for many sarcoma cases, affecting the accuracy of the National Cancer Data Base, National Inpatient Sample and other national databases. This meeting highlighted advances in sarcoma research and also featured symposia on basic science; medical, pediatric and young adult oncology; and new research technologies.

Sarcomas are often coded by tumor location rather than type of malignancy. To prove that inaccurate coding can have an impact on the accuracy of national databases, researchers determined the variation in coding by comparing operative diagnostic codes – ICD-9 or ICD-10 – and tumor registrar diagnosis codes, ICD-O-3, for each to determine. They evaluated coding practices to identify errors at a single high-volume sarcoma center.

Sarcoma diagnoses were confirmed from operative pathology reports. Of the total 2,715 individual soft tissue and bone oncologic surgeries performed between 2012 and 2016, 1,237 had a histologic diagnosis of sarcoma with pathology confirmation.

Of these cases,

  • Only 63% (n = 764) appeared accurately coded as sarcoma resections based on ICD-9/ICD-10 codes
  • 16% (n = 180) were coded as a non-oncologic diagnosis, and
  • 22% (n = 260) were coded by the organ, such as gastrointestinal, breast, hematologic, gynecologic, thoracic, cutaneous or “other” cancers

It was found that 72% of orthopedic oncology cases and 57% of surgical oncology sarcoma cases were accurately coded.

While evaluating ICD-O-3 codes, they found that

  • 631 of 1,054 patients (60%) had accurate coding
  • 26 (2%) were coded as “other cancer,” and
  • 397 (38%) were not included on the tumor registry
  • 46% percent of gastrointestinal stromal tumors and 72% of breast angiosarcomas also were coded incorrectly

According to the lead author of the study, “Potential solutions include multidisciplinary discussions to create recommendations for future ICD-9 or ICD-10 coding, and we want to streamline the sarcoma coding process at institutions as well.”

Inaccurate medical coding can mislead insurance companies regarding the patient’s condition and treatment provided, resulting in reimbursement issues for providers. Error-free reports can be created either with outsourced medical billing or by training hospital staff on the correct coding regulations.

Meghann Drella

Join Us Our Newsletter

Stay informed with our latest updates and insights.


By submitting, you consent to receive emails with a SafeUnsubscribe® link included.

Related Posts

5 Ways Medical Coding Accuracy Impacts Your Practice Revenue

5 Ways Medical Coding Accuracy Impacts Your Practice Revenue

Did you know? Medical coding errors alone are responsible for an eye-watering $36 billion-drain in the form of lost revenue, rejected claims and fines! That’s not pocket change, but a hard hit to your practice’s bottom line. The good news? Well, this loss isn’t...

Differentiating Between Upcoding and Downcoding in Medical Billing

Differentiating Between Upcoding and Downcoding in Medical Billing

Claim submission and denial management are the two steps that typically comprise the major portion of the medical billing workflow. While these steps are the key to obtaining proper reimbursements for healthcare providers, claims would not receive approval from payers...